Surely no one is enjoying the current downturn more than insolvency specialist Begbies Traynor, which has beaten forecasts for last year and foresees at least two more years of these superlative conditions.
Businesses don’t get much more counter-cyclical than the group’s core insolvency administration arm, which handled recent high-profile cases such as Silverjet and Carlyle Capital, and contributes over three-quarters of revenues. After a slow previous year and a quiet first half, depressed by the market’s free and easy credit conditions, Begbies was rewarded for maintaining its expansionary plans as insolvencies began to mushroom last autumn.
However, held back somewhat by the first half performance, pre-tax profits from continuing operations slipped from £8.5 to £5.7m in the year to April on sales up 14.8% to £48.1m. Executive chairman Ric Traynor says he intends to ‘sell or wind down’ its consumer debt arm as ‘the market was over-hyped and it’s now not an exciting business’.
But the future surely looks more exhilarating for the company, with the credit crunch resulting in ‘four times as many’ companies experiencing ‘critical problems’ than last year. Ric Traynor observes that having already taken ‘our fair share’ in the sharp increase in the number of businesses going into insolvency, ‘we see that trend continuing this year, next year and into 2010’.
All in all, it looks good news for the company, which looks a pretty non-toxic investment in these astringent times and is likely to soon enjoy upgrades on the current consensus forecasts of 8p earnings for the current year. Backed here in 2005 at 55.5p, the shares have risen above £2 and wavered to a recent low of 88p last December. They are worth buying.
Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.
Market cap: £128.99m
PE Forecast: 19.9
Share price: 159p
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.
Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.
London pub operator The Capital Pub Company is seeing continuing sales growth on the back of a surprisingly resilient market.